ArticleAnnals of medicine and surgery (2012)2026
Effects of growth hormone therapy on facial anthropometric features in children with growth disorders: a cohort study.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite the relatively widespread use of growth hormone (GH), information on its impact on craniofacial development remains limited. This study aims to assess changes in various facial anthropometric features in children receiving GH therapy for growth-related disorders and compare them with a control group. Methods: The study included 32 participants (25 girls and 7 boys), aged 9-13 years, who were supposed to receive GH therapy for height disorders. A control group of 32 individuals, matched by gender, age, and ethnicity, was also selected. Facial anthropometric dimensions, including six measurements (ala-ala, zy-zy, sn-gn, n-gn, t-sn, and t-gn) and three ratios [(n-gn)/(zy-zy), (sn-gn)/(n-gn), and (t-sn)/(t-gn)], were assessed and compared at the beginning and after 6 months. Results: After 6 months, the GH group showed the greatest growth changes in zy-zy (3.89 ± 2.66 mm) and t-gn (3.64 ± 1.71 mm), whereas the control group exhibited the greatest changes in t-gn (1.51 ± 0.88 mm). Minimal changes were observed in ala-ala for both groups. Additionally, the GH group demonstrated a significantly greater (sn-gn)/(n-gn) ratio compared to the control group ( Conclusion: Within the limitations of this study, the results indicated that short-term administration of GH for 6 months in healthy children with growth disorders significantly influenced facial anthropometric dimensions compared to the control group. Initial observations revealed an increase in facial width, along with the growth of the mandible. Further longer-term studies are recommended to confirm these preliminary trends.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.